How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

卷:127

Review

Bangma, Dorien F.^1,2  Tucha, Oliver^1,3,4  De Deyn, Peter P.^5,6,7,8,9  Koerts, Janneke¹ 

[1] Univ Groningen, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands

[2] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands

[3] Univ Med Ctr Rostock, Dept Psychiat & Psychotherapy, Rostock, Germany

[4] Natl Univ Ireland, Maynooth Univ, Dept Psychol, Maynooth, Kildare, Ireland

[5] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands

[6] Univ Med Ctr Groningen, Alzheimer Ctr Groningen, Groningen, Netherlands

[7] Univ Antwerp, Inst Born Bunge, Antwerp, Belgium

[8] Middelheim Hosp, Dept Neurol, Antwerp, Belgium

[9] Middelheim Hosp, Memory Clin, Antwerp, Belgium

关键词: Financial decision-making;    Money management;    Financial capability;    Financial competence;    Financial capacity;    Finances;    Monetary;    Cognition;    Neurodegenerative diseases;    Alzheimer's disease;    Mild cognitive impairment;    Frontotemporal Dementia;    Parkinson's disease;    Multiple sclerosis;    Huntington's disease;   

DOI  :  10.1016/j.neubiorev.2021.05.021

来源: Elsevier

【 摘 要 】

Self and proxy reported questionnaires indicate that people living with a neurodegenerative disease (NDD) have more difficulties with financial decision-making (FDM) than healthy controls. Self-reports, however, rely on adequate insight into everyday functioning and might, therefore, be less reliable. The present study provides a comprehensive overview and meta-analysis of studies evaluating FDM in people living with an NDD. For this, the reliability of performance-based tests to consistently identify FDM difficulties in people living with an NDD compared to healthy controls is evaluated. Furthermore, the associations between FDM and disease severity, performances on standard measures of cognition and demographics are evaluated. All 47 included articles, consistently reported lower performances on performance-based FDM tests of people living with an NDD (including Alzheimer's disease, mild cognitive impairment, frontotemporal dementia, Parkinson's disease, multiple sclerosis or Huntington's disease) compared to healthy controls. The majority of studies, however, focused on Alzheimer's disease and mild cognitive impairment (k = 38). FDM performance appears to be related to cognitive decline, specifically in working memory, processing speed and numeracy.

【 授权许可】

Free